Search Results
| No. |
VISDB ID▲▼ |
Virus Name▲▼ |
Subtype▲▼ |
Virus Genome▲▼ |
Breakpoint 1▲▼ |
Breakpoint 2▲▼ |
Human Genome▲▼ |
Chr▲▼ |
Start▲▼ |
End▲▼ |
Loci▲▼ |
Target Gene▲▼ |
Sample Type▲▼ |
Disease▲▼ |
Method▲▼ |
PubMed ID▲▼ |
Year▲▼ |
Curated Way▲▼ |
| 2271 |
TVIS20024035
|
Human Papillomavirus |
HPV16 |
K02718 |
4478 |
- |
hg38 |
chr22 |
11582190 |
11582190 |
p11.2 |
- |
Tumor |
Cervical cancer |
HPV capture sequencing |
35968887 |
2022 |
Curated |
| 2272 |
TVIS20024125
|
Human Papillomavirus |
HPV16 |
K02718 |
2745 |
- |
hg38 |
chr22 |
19065131 |
19065131 |
q11.21 |
DGCR2 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 2273 |
TVIS20024217
|
Human Papillomavirus |
HPV16 |
K02718 |
3200 |
- |
hg38 |
chr22 |
40684421 |
40684421 |
q13.2 |
ENSG00000289292 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 2274 |
TVIS20024249
|
Human Papillomavirus |
HPV16 |
K02718 |
3401 |
- |
hg38 |
chr22 |
40677011 |
40677011 |
q13.2 |
ENSG00000289292 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 2275 |
TVIS20024260
|
Human Papillomavirus |
HPV16 |
K02718 |
3963 |
- |
hg38 |
chr22 |
40665667 |
40665667 |
q13.2 |
ENSG00000289292 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 2276 |
TVIS20024297
|
Human Papillomavirus |
HPV16 |
K02718 |
2066 |
- |
hg38 |
chr22 |
40683520 |
40683520 |
q13.2 |
ENSG00000289292 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 2277 |
TVIS20024430
|
Human Papillomavirus |
HPV16 |
K02718 |
1588 |
- |
hg38 |
chr22 |
31329152 |
31329152 |
q12.2 |
PIK3IP1-DT, PATZ1 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 2278 |
TVIS20024431
|
Human Papillomavirus |
HPV16 |
K02718 |
3468 |
- |
hg38 |
chr22 |
31305785 |
31305785 |
q12.2 |
PIK3IP1-DT |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 2279 |
TVIS20024604
|
Human Papillomavirus |
HPV16 |
K02718 |
3547 |
- |
hg38 |
chr22 |
44612651 |
44612651 |
q13.31 |
LINC00229 |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |
| 2280 |
TVIS20024703
|
Human Papillomavirus |
HPV16 |
K02718 |
1759 |
- |
hg38 |
chr22 |
12091269 |
12091269 |
p11.2 |
- |
Tumor |
Cervical cancer |
EBV capture sequencing, followed by Viral Integration Pathway Analysis (VIPA) pipeline |
35968887 |
2022 |
Curated |